ArticleCurrent oncology reports2007

Clinical trials in metastatic hormone-refractory prostate cancer: improving docetaxel therapy by targeting bone-related growth factors.

Daniel P PetrylakPubMed ↗Publisher ↗

No numbers read from the abstract.